
ResMed RMD
$ 258.18
-0.04%
Annual report 2022
added 08-12-2022
Country |
|
IPO year |
- |
Industry |
Medical instruments |
Stock Exchange |
NYSESPB |
Shares |
146 M |
Market Cap[1] |
$ 37.7 B |
EBITDA (LTM) |
$ 1.46 B |
P/E (LTM) |
37.99 |
P/S (LTM) |
8.43 |
EPS (LTM) |
6.78 |
Other stocks of industry "Medical instruments"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Luminex Corporation
LMNX
|
- | - | $ 1.75 B | Nasdaq Global Select Market | ||
|
Akers Biosciences, Inc.
AKER
|
- | -9.52 % | $ 20.6 M | Nasdaq Capital Market | ||
|
Ekso Bionics Holdings
EKSO
|
$ 10.68 | 6.8 % | $ 25.9 M | Nasdaq Capital Market | ||
|
AtriCure
ATRC
|
$ 31.07 | -1.24 % | $ 1.48 B | Nasdaq Global Market,SPB | ||
|
Atrion Corporation
ATRI
|
- | - | $ 810 M | Nasdaq Global Select Market,SPB | ||
|
Isoray
ISR
|
- | 0.03 % | $ 108 M | NYSE American | ||
|
The Cooper Companies
COO
|
$ 81.58 | -2.15 % | $ 16.2 B | NYSE,SPB | ||
|
Alcon
ALC
|
$ 83.61 | 0.64 % | $ 40.4 B | NYSE | ||
|
iRhythm Technologies
IRTC
|
$ 127.84 | 1.58 % | $ 4.09 B | Nasdaq Global Select Market,SPB | ||
|
Antares Pharma, Inc.
ATRS
|
- | - | $ 955 M | Nasdaq Capital Market | ||
|
Cantel Medical Corp.
CMD
|
- | -1.18 % | $ 3.4 B | NYSE | ||
|
CRH Medical Corporation
CRHM
|
- | - | $ 282 M | NYSE American | ||
|
Repro Med Systems
KRMD
|
$ 4.89 | 2.52 % | $ 223 M | Nasdaq Capital Market | ||
|
Hill-Rom Holdings, Inc.
HRC
|
- | -0.05 % | $ 10.3 B | NYSE,SPB | ||
|
LeMaitre Vascular
LMAT
|
$ 106.77 | -1.0 % | $ 2.42 B | Nasdaq Global Market,SPB | ||
|
Masimo Corporation
MASI
|
$ 175.5 | 0.08 % | $ 9.35 B | Nasdaq Global Select Market,SPB | ||
|
Microbot Medical
MBOT
|
$ 2.51 | 4.81 % | $ 25.6 M | Nasdaq Global Select Market | ||
|
Baxter International
BAX
|
$ 18.91 | -0.63 % | $ 9.7 B | NYSE,SPB | ||
|
Varian Medical Systems, Inc.
VAR
|
- | -0.02 % | $ 16.3 B | NYSE | ||
|
Glaukos Corporation
GKOS
|
$ 116.05 | -1.44 % | $ 5.62 B | NYSE,SPB | ||
|
Haemonetics Corporation
HAE
|
$ 65.12 | -0.78 % | $ 3.28 B | NYSE,SPB | ||
|
Predictive Oncology
POAI
|
- | - | $ 31.1 M | Nasdaq Capital Market | ||
|
Harvard Bioscience
HBIO
|
$ 0.58 | 2.6 % | $ 24.6 M | Nasdaq Global Market | ||
|
Becton, Dickinson and Company
BDX
|
$ 171.33 | -1.65 % | $ 49.3 B | NYSE,SPB | ||
|
Retractable Technologies
RVP
|
$ 0.68 | -3.02 % | $ 20.4 M | NYSE American | ||
|
AngioDynamics
ANGO
|
$ 11.0 | -0.36 % | $ 449 M | Nasdaq Global Select Market | ||
|
BioLife Solutions
BLFS
|
$ 20.63 | 2.28 % | $ 950 M | Nasdaq Global Select Market | ||
|
Nephros
NEPH
|
$ 3.92 | 1.29 % | $ 40.7 M | Nasdaq Global Select Market | ||
|
electroCore
ECOR
|
$ 7.66 | 0.66 % | $ 42.2 K | Nasdaq Global Select Market | ||
|
STERIS plc
STE
|
$ 244.4 | 0.43 % | $ 24.1 B | NYSE,SPB | ||
|
Envista Holdings Corporation
NVST
|
$ 28.3 | -1.26 % | $ 4.75 B | NYSE | ||
|
Pulse Biosciences
PLSE
|
$ 18.27 | 1.78 % | $ 1.23 B | Nasdaq Global Select Market | ||
|
Teleflex Incorporated
TFX
|
$ 119.77 | -1.95 % | $ 5.34 B | NYSE,SPB | ||
|
ICU Medical
ICUI
|
$ 142.9 | 0.17 % | $ 3.52 B | Nasdaq Global Select Market,SPB | ||
|
InfuSystem Holdings
INFU
|
$ 9.47 | 3.16 % | $ 196 M | NYSE American | ||
|
Intuitive Surgical
ISRG
|
$ 503.65 | 1.25 % | $ 180 B | Nasdaq Global Select Market,SPB | ||
|
Repligen Corporation
RGEN
|
$ 125.6 | 2.06 % | $ 7 M | Nasdaq Global Select Market,SPB | ||
|
Merit Medical Systems
MMSI
|
$ 74.64 | -0.28 % | $ 4.42 B | Nasdaq Global Select Market,SPB | ||
|
STAAR Surgical Company
STAA
|
$ 18.9 | -0.11 % | $ 937 M | Nasdaq Global Market,SPB | ||
|
NeuroMetrix
NURO
|
- | 5.05 % | $ 9.02 M | Nasdaq Global Select Market | ||
|
OraSure Technologies
OSUR
|
$ 3.0 | 0.5 % | $ 223 M | Nasdaq Global Select Market,SPB | ||
|
Utah Medical Products
UTMD
|
$ 66.88 | 0.56 % | $ 243 M | Nasdaq Global Select Market | ||
|
Pro-Dex
PDEX
|
$ 49.42 | 4.01 % | $ 162 M | Nasdaq Global Select Market | ||
|
West Pharmaceutical Services
WST
|
$ 249.34 | -0.74 % | $ 18 B | NYSE,SPB | ||
|
DENTSPLY SIRONA
XRAY
|
$ 13.41 | 0.83 % | $ 2.67 B | Nasdaq Global Select Market,SPB | ||
|
Stereotaxis
STXS
|
$ 2.21 | 3.04 % | $ 178 M | NYSE American | ||
|
Milestone Scientific
MLSS
|
$ 0.28 | -0.64 % | $ 22.3 M | NYSE American |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.